The hydrogels with the α3/α5β1 integrin-specific fragment-stimulated formation of vasculature with organization and morphological characteristics similar to native blood vessels, whereas αvβ3 ...

and α5β1-acting drugs for pulmonary hypertensive diseases. Beyond the integrin area, Morphic is also working on TL1A and IL-23 therapies for IBD, which are also in preclinical development and ...